Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate

Journal of Drug Targeting

Volumn 6, Issue 3, 1998, Pages 207-214

  Bernkop Schnürch, Andreas ^a   Krauland, Alexander ^a   Valenta, Claudia ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chymotrypsin; Drug delivery system; Elastase; Enzyme inhibition; Peroral administration of (poly)peptides; Trypsin

Indexed keywords

BOWMAN BIRK INHIBITOR; CHITOSAN; CHYMOTRYPSIN; EDETIC ACID; ELASTASE; INSULIN; MANNITOL; SERINE PROTEINASE; TRYPSIN;

ARTICLE; CONJUGATE; DRUG DELIVERY SYSTEM; HOMOGENATE; INTESTINE FLUID; PRIORITY JOURNAL; PROTECTION; TABLET COMPRESSION; TEMPERATURE;

EID: 0032411591     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869808997895     Document Type: Article

References (25)

1. 2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm. Res., 5, 305-308.
2. Bernkop-Schnürch, A. (1997) Strategien zur peroralen Applikation von Peptid- und Proteinwirkstoffen. Sci. Pharm., 65, 61-81.
3. Bernkop-Schnürch, A. (1998) The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release, in press.
4. Bernkop-Schnürch, A. and Apprich, I. (1997) Synthesis and evaluation of a modified mucoadhesive polymer protecting from α-chymotrypsinic degradation. Int. J. Pharm., 146, 247-254.
5. Bernkop-Schnürch, A. and Dundalek, K. (1996) Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation. Int. J. Pharm., 138, 75-83.
6. Bernkop-Schnürch, A. and Göckel, N.C. (1997) Development and analysis of a polymer protecting from luminal enzymatic degradation caused by α-chymotrypsin. Drug Dev. Ind. Pharm., 23, 733-740.
7. Bernkop-Schnürch, A. and Krajicek, M.E. (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J. Control. Release, 50, 215-223.
8. Bernkop-Schnürch, A. and Marschütz, M. (1997) Development and in vitro evaluation of systems to protect peptide drugs from aminopeptidase N. Pharm. Res., 14, 181-185.
9. Bernkop-Schnürch, A. and Pasta, M. (1998) Intestinal peptide and protein delivery: novel bioadhesive drug carrier-matrix shielding from enzymatic attack. J. Pharm. Sci., in press.
10. Bernkop-Schnürch, A. and Scerbe-Saiko, A. (1998) Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins. Pharm. Res., 15, 267-273.
11. Bernkop-Schnürch, A., Bratengeyer, I. and Valenta, C. (1997a) Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation. Int. J. Pharm., 157, 17-25.
12. Bernkop-Schnürch, A., Schwarz, G.H. and Kratzel, M. (1997b) Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides. J. Control. Release, 47, 113-121.
13. Bernkop-Schnürch, A., Paikl, Ch. and Valenta, C. (1997c) Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N. Pharm. Res., 14, 917-922.
14. Bernkop-Schnürch, A., Humenberger, C. and Valenta, C. (1998) Basic studies on bioadhesive delivery systems for peptide and protein drugs. Int. J. Pharm., in press.
15. Birk, Y. (1985) The Bowman-Birk inhibitor. Int. J. Peptide Protein Res., 25, 113-131.
16. Garner, Ch.W. and Behal, F.J. (1974) Human liver aminopeptidase. Role of metal ions in mechanism of action. Biochemistry, 13, 3227-3233.
17. Kotzé, A.F., Lueßen, H.L., Deleeuw, B.J., de Boer, B.G., Verhoef, J.C. and Junginger, E.H. (1997) N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces - in vitro evaluation in intestinal epithelial cells (CACO-2). Pharm. Res., 14, 1197-1202.
18. Lehr, C.-M. (1994) Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug. Car. Syst., 11, 119-160.
19. Lueßen, H.L., Verhoef, J.C., Borchard, G., Lehr, C.-M., de Boer, A.G. and Junginger, H.E. (1995) Mucoadhesive polymers in the peroral peptide drug delivery: II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm. Res., 12, 1293-1298.
20. Lueßen, H.L., de Leeuw, B.J., Pérard, D., Lehr, C.-M., de Boer, A.G., Verhoef, J.C. and Junginger, E.H. (1996) Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur. J. Pharm. Sci., 4, 117-128.
21. Lueßen, H.L., Rentel, C-O., Kotzé, A.F., Lehr, C.-M., de Boer, A.G., Verhoef, J.C. and Junginger, H.E. (1997) Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Control. Release, 45, 15-23.
22. Reseland, J.E., Holm, H., Jacobsen, M.B., Jenssen, T.G. and Hanssen, L.E. (1996) Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion. Hum. Clin. Nutr., 126, 634-642.
23. Seidl, D.S. and Liener, I.E. (1972) Isolation and properties of complexes of the Bowman-Birk soybean inhibitor with trypsin and chymotrypsin. J. Biol. Chem., 247, 3533-3538.
24. Valenta, C., Christen, B. and Bernkop-Schnürch, A. (1998) Chitosan-EDTA conjugate: A novel polymer for topical used gels. J. Pharm. Pharmacol., 50, 445-452.
25. Woodley, J.F. (1994) Enzymatic barriers for GI peptide and protein delivery. Crit. Rev. Ther. Drug Car. Syst., 11, 61-95.